Objective: To observe the after-effect duration of kidney-nourishing and marrow-replenishing therapy on Mediterranean anemia. Methods: To observe the kidney-nourishing and marrow-replenishing therapy on 58 cases of Mediterranean anemia and the influence of various relative factors on the after-effect duration. Results: The after-effect duration on 58 cases varied from 3-6 months, about 4 months on average, and was not influenced by sex, clinical types, genetic types, types of Mediterranean anemia and other factors. Conclusion: Kidney-nourishing and marrow-replenishing therapy used to treat Mediterranean anemia can not only produce good therapeutic effect during treatment but also keep after effect lasting for about 4 months, indicating that the therapy used to treat Mediterranean anemia has good clinical after effect.
Mediterranean anemia is a chronic hemolytic disease caused by imbalance of peptide chain because genetic mutation or defect of one globin or more inhibits the synthesis of its peptide chain. In order to determine the after effect of kidney-nourishing and marrowreplenishing therapy on Mediterranean anemia, the research team observed the after-effect duration of the therapy on 58 cases from 1993 to 2004.
CLINICAL MATERIALS

Criteria for Diagnosis and Inclusion
According to the criteria for diagnosing Mediterranean anemia in "Criteria for Diagnosis and Therapeutic Effect on Hematopathy" edited by ZHANG Zhi-nan, 1 patients with -Mediterranean anemia hemoglobin H disease (HbH disease) as well as severe or moderate -Mediterranean anemia with no blood transfusion or in take of anti-anemia drug in recent half a year.
Criteria for Exclusion 1) Patients have immunologic deficiency or other
primary diseases of the liver, kidney and blood system. 2) Patients do not take drugs according to instructions or their data are incomplete, thus influencing the determination of therapeutic effect. 
General Data
METHODS
Therapeutic Method
Chinese drugs for nourishing the kidney and replenishing marrow (capsule and granule for replenishing marrow and generating blood) were used in the treatment for 2-3 months. During observation, patients were asked to have no blood transfusion, but keep on taking the drugs. Index and Method of Observation 1) Observations on the after-effect duration: After treatment, the effective cases were asked to come back to hospital at a fixed time every month for reexamination of their blood parameters: hemoglobin concentration (Hb), red cell count (RBC) and reticulocyte count (Ret). The time from the day of withdraw to the day when hemoglobin concentration reduces to the level before treatment is defined as the time of maintaining therapeutic effect. If Hb is equal to or less than the level before treatment, the previous time of reexamination is regarded as valid date calculated by months. 2) Influence of relevant factors on the after-effect duration: Observations were carried out on the influence of sex, clinical type, genetic type and Mediterranean anemia type on the duration of lasting effect for Mediterranean anemia patients.
Criteria for Therapeutic Effect
In reference to "Criteria for Dagnosis and Therapeutic Effect on Hematopathy" edited by ZHANG Zhi-nan, 1 increase in red cell count and reticulocyte count (Hb, RBC, Ret) and increase in hemoglobin concentration (Hb) to more than 5 g/L is regarded as effective. Increase in reticulocyte count (Ret) alone is not regarded as an effective case.
Statistical Method
SPSS10.0 software is used. Enumeration data is used for frequency statistics, measurement data is expressed in ( x ±s). Paired t test, grouped t test and
variance analysis of single factor are applied respectively according to data types.
RESULTS
Observations on The Duration of The After-Effect
Among 58 patients, 23 cases accounting for 39.7% had the therapeutic effect lasted for 3 months, 16 cases accounting for 27.6% for 6 months, 6 cases accounting for 10.3% for 2 months, 6 cases accounting for 10.3% for 4 months, 5 cases accounting for 8.6% for 1 month, 1 case accounting for 1.7% for 5 months and 1 case accounting for 1.7% for 11 months. According to the statistic analysis that 79.3% of the 58 patients had the effect lasted for 3-6 months, 3.8±1.9 months on average.
As shown in Table 1 , the level of hemoglobin concentration, red cell count and reticulocyte count of all the 58 patients in the after-effect duration determined by months was higher than the level before treatment (P<0.05 or P<0.01), indicating that the after-effect duration still has a tendency to increase.
Influence of Relevant Factors on The After-Effect Duration
1) Influence of sex on the after-effect duration: As shown in Table 2 , there is no statistical difference between males and females in the after-effect duration (P>0.05), indicating that after treatment with Chinese drugs for nourishing kidney and replenishing marrow, the duration of after effect is not influenced by sex.
2) Influence of clinical types on the duration of after effect: As shown in Table 3 , there is no statistical difference between severe type and moderate type in the after-effect duration (P>0.05), indicating that after treatment with Chinese drugs for nourishing kidney and replenishing marrow, the duration of after effect is not influenced by clinical types.
3) Influence of genetic types on the after-effect duration: As shown in Table 4 , there is no statistical difference among homozygous type, dual heterozygous type and heterozygous type in the aftereffect duration (P>0.05), indicating that after treatment with Chinese drugs for nourishing kidney and replenishing marrow, the after-effect duration is not influenced by genetic types.
4) Influence of Mediterranean anemia types on the after-effect duration: As shown in Table 5 , there is no statistical difference between Mediterranean anemia and -Mediterranean anemia in the aftereffect duration (P>0.05), indicating that after treatment with Chinese drugs for nourishing kidney and replenishing marrow, the after-effect duration is not influenced by Mediterranean anemia types. In order to further determine the after effect of kidney-nourishing and marrow-replenishing therapy on Mediterranean anemia, the research team has observed the after-effect duration on some patients treated with kidney-nourishing and marrowreplenishing therapy. Through statistics, 58 patients generally had the after-effect duration for 3-6 months, about 4 months on average. Further analysis has shown that the after-effect duration is not influenced by sex, clinical types, genetic types and Mediterranean anemia types. Clinical data have shown that the average life-span of mature red cells is 120 days in healthy people and 30-40 days in Mediterranean anemia patients. Owing to greatly shortened life-span of red cells, Mediterranean anemia patients are clinically characterized by hemolysis, anemia and other pathological changes. 4 months after drug withdraw, Mediterranean anemia patients treated with kidney-nourishing and marrowreplenishing therapy can still keep hemoglobin concentration and red cell count higher than the level before treatment, indicating that kidney-nourishing and marrow-replenishing therapy can effectively influence hemolysis and anemia of Mediterranean anemia patients. Yet, concrete pathogenesis and functions remain to be further studied.
In general, the following conclusion can be drawn from the observations during follow-up visits. The treatment of Mediterranean anemia with kidneynourishing and marrow-replenishing therapy can not only achieve good therapeutic effect during treatment but also let the therapeutic effect last for about 4 months after drug withdraw, indicating that kidneynourishing and marrow-replenishing therapy has good after effect on Mediterranean anemia.
